{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,10,1]],"date-time":"2026-10-01T00:56:45Z","timestamp":1790816205440,"version":"4.1.0"},"reference-count":41,"publisher":"Elsevier BV","issue":"3","license":[{"start":{"date-parts":[[2011,8,1]],"date-time":"2011-08-01T00:00:00Z","timestamp":1312156800000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/tdm\/userlicense\/1.0\/"},{"start":{"date-parts":[[2015,12,7]],"date-time":"2015-12-07T00:00:00Z","timestamp":1449446400000},"content-version":"vor","delay-in-days":1589,"URL":"https:\/\/www.elsevier.com\/open-access\/userlicense\/1.0\/"}],"content-domain":{"domain":[],"crossmark-restriction":false},"short-container-title":["Kidney International"],"published-print":{"date-parts":[[2011,8]]},"DOI":"10.1038\/ki.2011.119","type":"journal-article","created":{"date-parts":[[2011,5,4]],"date-time":"2011-05-04T13:48:55Z","timestamp":1304516935000},"page":"295-301","source":"Crossref","is-referenced-by-count":122,"title":["Short-term effects of tolvaptan on renal function and volume in patients with autosomal dominant polycystic kidney disease"],"prefix":"10.1016","volume":"80","author":[{"given":"Maria V.","family":"Irazabal","sequence":"first","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Vicente E.","family":"Torres","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Marie C.","family":"Hogan","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"James","family":"Glockner","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Bernard F.","family":"King","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Troy G.","family":"Ofstie","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Holly B.","family":"Krasa","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"John","family":"Ouyang","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Frank S.","family":"Czerwiec","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"78","reference":[{"key":"10.1038\/ki.2011.119_bb0010","doi-asserted-by":"crossref","first-page":"1323","DOI":"10.1038\/nm935","article-title":"Inhibition of renal cystic disease development and progression by a vasopressin V2 receptor antagonist","volume":"9","author":"Gattone","year":"2003","journal-title":"Nat Med"},{"key":"10.1038\/ki.2011.119_bb0015","doi-asserted-by":"crossref","first-page":"363","DOI":"10.1038\/nm1004","article-title":"Effective treatment of an orthologous model of autosomal dominant polycystic kidney disease","volume":"10","author":"Torres","year":"2004","journal-title":"Nat Med"},{"key":"10.1038\/ki.2011.119_bb0020","doi-asserted-by":"crossref","first-page":"846","DOI":"10.1681\/ASN.2004121090","article-title":"Effectiveness of vasopressin V2 receptor antagonists OPC-31260 and OPC-41061 on polycystic kidney disease development in the PCK rat","volume":"16","author":"Wang","year":"2005","journal-title":"J Am Soc Nephrol"},{"key":"10.1038\/ki.2011.119_bb0025","doi-asserted-by":"crossref","first-page":"964","DOI":"10.1111\/j.1523-1755.2004.00843.x","article-title":"Cyclic AMP promotes growth and secretion in human polycystic kidney epithelial cells","volume":"66","author":"Belibi","year":"2004","journal-title":"Kidney Int"},{"key":"10.1038\/ki.2011.119_bb0030","doi-asserted-by":"crossref","first-page":"1460","DOI":"10.1046\/j.1523-1755.2000.00991.x","article-title":"cAMP stimulates the in vitro proliferation of renal cyst epithelial cells by activating the extracellular signal-regulated kinase pathway","volume":"57","author":"Yamaguchi","year":"2000","journal-title":"Kidney Int"},{"key":"10.1038\/ki.2011.119_bb0035","doi-asserted-by":"crossref","first-page":"1319","DOI":"10.1001\/jama.297.12.1319","article-title":"Effects of oral tolvaptan in patients hospitalized for worsening heart failure: the EVEREST Outcome Trial","volume":"297","author":"Konstam","year":"2007","journal-title":"JAMA"},{"key":"10.1038\/ki.2011.119_bb0040","doi-asserted-by":"crossref","first-page":"2099","DOI":"10.1056\/NEJMoa065181","article-title":"Tolvaptan, a selective oral vasopressin V2-receptor antagonist, for hyponatremia","volume":"355","author":"Schrier","year":"2006","journal-title":"N Engl J Med"},{"key":"10.1038\/ki.2011.119_bb0045","first-page":"746A","article-title":"Phase 2 open-label study to determine long-term safety, tolerability and efficiacy of split-dose Tolvaptan in ADPKD","volume":"20","author":"Torres","year":"2009","journal-title":"J Am Soc Nephrol"},{"key":"10.1038\/ki.2011.119_bb0050","first-page":"F428","article-title":"Glomerular adaptations to chronic dietary salt restriction or excess","volume":"238","author":"Schor","year":"1980","journal-title":"Am J Physiol"},{"key":"10.1038\/ki.2011.119_bb0055","first-page":"361A","article-title":"Acute and chronic osmostasis after vassopressin V2 receptor inhibiton with Tolvaptan in ADPKD","volume":"16","author":"Grantham","year":"2005","journal-title":"J Am Soc Nephrol"},{"key":"10.1038\/ki.2011.119_bb0060","first-page":"F819","article-title":"Influence of vasopressin on renal hemodynamics in conscious Brattleboro rats","volume":"246","author":"Gellai","year":"1984","journal-title":"Am J Physiol"},{"key":"10.1038\/ki.2011.119_bb0065","doi-asserted-by":"crossref","first-page":"719","DOI":"10.1097\/00005344-199011000-00005","article-title":"Renal versus hindquarter hemodynamic responses to vasopressin in conscious rats","volume":"16","author":"Harrison-Bernard","year":"1990","journal-title":"J Cardiovasc Pharmacol"},{"key":"10.1038\/ki.2011.119_bb0070","first-page":"H663","article-title":"Cardiac output distribution during vasopressin infusion or dehydration in conscious dogs","volume":"243","author":"Liard","year":"1982","journal-title":"Am J Physiol"},{"key":"10.1038\/ki.2011.119_bb0075","doi-asserted-by":"crossref","first-page":"197","DOI":"10.1111\/j.1365-201X.2004.01352.x","article-title":"The effect of AVP-V1 receptor stimulation on local GFR in the rat kidney","volume":"182","author":"Roald","year":"2004","journal-title":"Acta Physiol Scand"},{"key":"10.1038\/ki.2011.119_bb0080","doi-asserted-by":"crossref","first-page":"223S","DOI":"10.1111\/j.1469-445X.2000.tb00027.x","article-title":"Control of the renal medullary circulation by vasopressin V1 and V2 eceptors in the rat","volume":"85 Spec No","author":"Cowley","year":"2000","journal-title":"Exp Physiol"},{"key":"10.1038\/ki.2011.119_rf0085","doi-asserted-by":"crossref","first-page":"323","DOI":"10.1007\/BF00588584","article-title":"The effect of antidiuretic hormone on the distribution of nephron filtration rates in rats with hereditary diabetes insipidus","volume":"330","author":"Davis","year":"1971","journal-title":"Pflugers Arch"},{"key":"10.1038\/ki.2011.119_bb0090","first-page":"F274","article-title":"Renal microvascular effects of vasopressin and vasopressin antagonists","volume":"256","author":"Edwards","year":"1989","journal-title":"Am J Physiol"},{"key":"10.1038\/ki.2011.119_bb0095","doi-asserted-by":"crossref","first-page":"1348","DOI":"10.1152\/ajplegacy.1970.219.5.1348","article-title":"Intrarenal distribution of blood flow in diabetes insipidus: role of ADH","volume":"219","author":"Fisher","year":"1970","journal-title":"Am J Physiol"},{"key":"10.1038\/ki.2011.119_bb0100","doi-asserted-by":"crossref","first-page":"326","DOI":"10.1016\/1056-8727(95)80033-B","article-title":"Effect of AVP.V1-receptor antagonist on urinary albumin excretion and renal hemodynamics in NIDDM nephropathy: role of AVP.V1-receptor","volume":"9","author":"Yamada","year":"1995","journal-title":"J Diabetes Complications"},{"key":"10.1038\/ki.2011.119_bb0105","doi-asserted-by":"crossref","first-page":"770","DOI":"10.1172\/JCI112034","article-title":"Effect of arginine vasopressin on renal medullary blood flow. A videomicroscopic study in the rat","volume":"76","author":"Zimmerhackl","year":"1985","journal-title":"J Clin Invest"},{"key":"10.1038\/ki.2011.119_bb0110","first-page":"F41","article-title":"Vasopressin receptors from cultured mesangial cells resemble V1a type","volume":"253","author":"Jard","year":"1987","journal-title":"Am J Physiol"},{"key":"10.1038\/ki.2011.119_bb0115","doi-asserted-by":"crossref","first-page":"442","DOI":"10.1038\/ki.1981.160","article-title":"Mechanisms of action of various hormones and vasoactive substances on glomerular ultrafiltration in the rat","volume":"20","author":"Schor","year":"1981","journal-title":"Kidney Int"},{"key":"10.1038\/ki.2011.119_bb0120","doi-asserted-by":"crossref","first-page":"372","DOI":"10.1016\/S0008-6363(01)00328-5","article-title":"Antidiuretic action of vasopressin: quantitative aspects and interaction between V1a and V2 receptor-mediated effects","volume":"51","author":"Bankir","year":"2001","journal-title":"Cardiovasc Res"},{"key":"10.1038\/ki.2011.119_bb0125","doi-asserted-by":"crossref","first-page":"842","DOI":"10.1681\/ASN.V76842","article-title":"Vasopressin increases glomerular filtration rate in conscious rats through its antidiuretic action","volume":"7","author":"Bouby","year":"1996","journal-title":"J Am Soc Nephrol"},{"key":"10.1038\/ki.2011.119_bb0130","doi-asserted-by":"crossref","first-page":"748","DOI":"10.1046\/j.1523-1755.2001.060002748.x","article-title":"Level of hydration and renal function in healthy humans","volume":"60","author":"Anastasio","year":"2001","journal-title":"Kidney Int"},{"key":"10.1038\/ki.2011.119_bb0135","first-page":"R53","article-title":"Antidiuretic effect of subnormal levels of arginine vasopressin in normal humans","volume":"259","author":"Andersen","year":"1990","journal-title":"Am J Physiol"},{"key":"10.1038\/ki.2011.119_bb0140","doi-asserted-by":"crossref","first-page":"310","DOI":"10.1056\/NEJM199307293290503","article-title":"The secretion of fluid by renal cysts from patients with autosomal dominant polycystic kidney disease","volume":"329","author":"Ye","year":"1993","journal-title":"New Eng J Med"},{"key":"10.1038\/ki.2011.119_bb0145","first-page":"365A","article-title":"Tolvaptan inhibits AVP-induced Cl-secretion and in vitro cyst growth of human ADPKD cyst epithelial cells","volume":"19","author":"Reif","year":"2008","journal-title":"J Am Soc Nephrol"},{"key":"10.1038\/ki.2011.119_bb0150","doi-asserted-by":"crossref","first-page":"376","DOI":"10.1016\/S0002-9343(97)00165-4","article-title":"Hyperuricemia as a clue for central diabetes insipidus (lack of V1 effect) in the differential diagnosis of polydipsia","volume":"103","author":"Decaux","year":"1997","journal-title":"Am J Med"},{"key":"10.1038\/ki.2011.119_bb0155","doi-asserted-by":"crossref","first-page":"1057","DOI":"10.1056\/NEJM197105132841903","article-title":"Hyperuricemia, a concomitant of congenital vasopressin-resistant diabetes insipidus in the adult","volume":"284","author":"Gorden","year":"1971","journal-title":"N Engl J Med"},{"key":"10.1038\/ki.2011.119_bb0160","doi-asserted-by":"crossref","first-page":"1920","DOI":"10.1681\/ASN.2004121079","article-title":"Vasopressin-V2 receptor stimulation reduces sodium excretion in healthy humans","volume":"16","author":"Bankir","year":"2005","journal-title":"J Am Soc Nephrol"},{"key":"10.1038\/ki.2011.119_bb0165","doi-asserted-by":"crossref","first-page":"1721","DOI":"10.1681\/ASN.2008010021","article-title":"Sodium excretion in response to vasopressin and selective vasopressin receptor antagonists","volume":"19","author":"Perucca","year":"2008","journal-title":"J Am Soc Nephrol"},{"key":"10.1038\/ki.2011.119_bb0170","doi-asserted-by":"crossref","first-page":"1024","DOI":"10.1038\/sj.ki.5000211","article-title":"Long-term effects of vasopressin on the subcellular localization of ENaC in the renal collecting system","volume":"69","author":"Sauter","year":"2006","journal-title":"Kidney Int"},{"key":"10.1038\/ki.2011.119_bb0175","doi-asserted-by":"crossref","first-page":"F502","DOI":"10.1152\/ajprenal.00476.2009","article-title":"Short-term stimulation of the thiazide-sensitive Na+-Cl- cotransporter by vasopressin involves phosphorylation and membrane translocation","volume":"298","author":"Mutig","year":"2010","journal-title":"Am J Physiol Renal Physiol"},{"key":"10.1038\/ki.2011.119_bb0180","doi-asserted-by":"crossref","first-page":"85","DOI":"10.1152\/physrev.2001.81.1.85","article-title":"Potassium transport in the mammalian collecting duct","volume":"81","author":"Muto","year":"2001","journal-title":"Physiol Rev"},{"key":"10.1038\/ki.2011.119_bb0185","doi-asserted-by":"crossref","first-page":"824","DOI":"10.1016\/S0140-6736(94)92026-5","article-title":"Evaluation of ultrasonographic diagnostic criteria for autosomal dominant polycystic kidney disease 1","volume":"343","author":"Ravine","year":"1994","journal-title":"Lancet"},{"key":"10.1038\/ki.2011.119_bb0190","doi-asserted-by":"crossref","first-page":"205","DOI":"10.1681\/ASN.2008050507","article-title":"Unified criteria for ultrasonographic diagnosis of ADPKD","volume":"20","author":"Pei","year":"2009","journal-title":"J Am Soc Nephrol"},{"key":"10.1038\/ki.2011.119_bb0195","doi-asserted-by":"crossref","first-page":"2250","DOI":"10.1046\/j.1523-1755.2001.00741.x","article-title":"Total body water reference values and prediction equations for adults","volume":"59","author":"Chumlea","year":"2001","journal-title":"Kidney Int"},{"key":"10.1038\/ki.2011.119_bb0200","doi-asserted-by":"crossref","first-page":"112","DOI":"10.2215\/CJN.00910306","article-title":"Magnetic resonance measurements of renal blood flow and disease progression in autosomal dominant polycystic kidney disease","volume":"2","author":"Torres","year":"2007","journal-title":"Clin J Am Soc Nephrol"},{"key":"10.1038\/ki.2011.119_bb0205","doi-asserted-by":"crossref","first-page":"2214","DOI":"10.1046\/j.1523-1755.2003.00326.x","article-title":"Magnetic resonance measurements of renal blood flow as a marker of disease severity in autosomal-dominant polycystic kidney disease","volume":"64","author":"King","year":"2003","journal-title":"Kidney Int"},{"key":"10.1038\/ki.2011.119_bb0210","doi-asserted-by":"crossref","first-page":"940","DOI":"10.1002\/mrm.22278","article-title":"Renal arterial blood flow measurement by breath-held MRI: accuracy in phantom scans and reproducibility in healthy subjects","volume":"63","author":"Dambreville","year":"2010","journal-title":"Magn Reson Med"}],"container-title":["Kidney International"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S0085253815550242?httpAccept=text\/plain","content-type":"text\/plain","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S0085253815550242?httpAccept=text\/xml","content-type":"text\/xml","content-version":"vor","intended-application":"text-mining"}],"deposited":{"date-parts":[[2021,11,22]],"date-time":"2021-11-22T15:50:24Z","timestamp":1637596224000},"score":1,"resource":{"primary":{"URL":"https:\/\/linkinghub.elsevier.com\/retrieve\/pii\/S0085253815550242"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2011,8]]},"references-count":41,"journal-issue":{"issue":"3","published-print":{"date-parts":[[2011,8]]}},"alternative-id":["S0085253815550242"],"URL":"https:\/\/doi.org\/10.1038\/ki.2011.119","relation":{},"ISSN":["0085-2538"],"issn-type":[{"value":"0085-2538","type":"print"}],"subject":[],"published":{"date-parts":[[2011,8]]}}}